-
1
-
-
0036654027
-
The peripheral dopaminergic system: Morphological analysis, functional and clinical applications
-
Amenta F, Ricci A, Tayebati SK, Zaccheo D. The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital J Anat Embryol 2002; 107: 145-167.
-
(2002)
Ital J Anat Embryol
, vol.107
, pp. 145-167
-
-
Amenta, F.1
Ricci, A.2
Tayebati, S.K.3
Zaccheo, D.4
-
2
-
-
78649821142
-
Minireview: New roles for peripheral dopamine on metabolic control and tumor growth: Let's seek the balance
-
Rubi B, Maechler P. Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance. Endocrinology 2010; 151: 5570-5581.
-
(2010)
Endocrinology
, vol.151
, pp. 5570-5581
-
-
Rubi, B.1
Maechler, P.2
-
3
-
-
0036228080
-
Dopamine, hypertension and obesity
-
Contreras F, Fouillioux C, Bolívar A, Simonovis N, Hernández-Hernández R, Armas-Hernandez MJ et al. Dopamine, hypertension and obesity. J Hum Hypertens 2002; 16: S13-S17.
-
(2002)
J Hum Hypertens
, vol.16
, pp. S13-S17
-
-
Contreras, F.1
Fouillioux, C.2
Bolívar, A.3
Simonovis, N.4
Hernández-Hernández, R.5
Armas-Hernandez, M.J.6
-
4
-
-
33644829284
-
Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: Analysis of dopamine receptor expression, location, development, function in wildtype and knock-out mice
-
Li ZS, Schmauss C, Cuenca A, Ratcliffe E, Gershon MD. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, function in wildtype and knock-out mice. J Neurosci 2006; 26: 2798-2807.
-
(2006)
J Neurosci
, vol.26
, pp. 2798-2807
-
-
Li, Z.S.1
Schmauss, C.2
Cuenca, A.3
Ratcliffe, E.4
Gershon, M.D.5
-
5
-
-
80053148733
-
Dopamine receptors in human adipocytes: Expression and functions
-
Borcherding DC, Hugo ER, Idelman G, De Silva A, Richtand NW, Loftus J et al. Dopamine receptors in human adipocytes: expression and functions. PLoS One 2011; 6: e25537.
-
(2011)
PLoS One
, vol.6
, pp. e25537
-
-
Borcherding, D.C.1
Hugo, E.R.2
Idelman, G.3
De Silva, A.4
Richtand, N.W.5
Loftus, J.6
-
6
-
-
6844250767
-
Dopamine receptors: From structure to function
-
Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev 1998; 78: 189-225.
-
(1998)
Physiol Rev
, vol.78
, pp. 189-225
-
-
Missale, C.1
Nash, S.R.2
Robinson, S.W.3
Jaber, M.4
Caron, M.G.5
-
7
-
-
0033848928
-
Coupling of dopamine receptor subtypes to multiple and diverse G proteins
-
Sidhu A, Niznik HB. Coupling of dopamine receptor subtypes to multiple and diverse G proteins. Int J Dev Neurosci 2000; 18: 669-677.
-
(2000)
Int J Dev Neurosci
, vol.18
, pp. 669-677
-
-
Sidhu, A.1
Niznik, H.B.2
-
8
-
-
79952032110
-
The physiology, signaling, pharmacology of dopamine receptors
-
Beaulieu JM, Gainetdinov RR. The physiology, signaling, pharmacology of dopamine receptors. Pharmacol Rev 2011; 63: 182-217.
-
(2011)
Pharmacol Rev
, vol.63
, pp. 182-217
-
-
Beaulieu, J.M.1
Gainetdinov, R.R.2
-
9
-
-
84873413896
-
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission
-
Arcangeli S, Tozzi A, Tantucci M, Spaccatini C, de Iure A, Costa C et al. Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. J Cereb Blood Flow Metab 2013; 33: 278-286.
-
(2013)
J Cereb Blood Flow Metab
, vol.33
, pp. 278-286
-
-
Arcangeli, S.1
Tozzi, A.2
Tantucci, M.3
Spaccatini, C.4
De Iure, A.5
Costa, C.6
-
10
-
-
77952944361
-
Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons
-
Lin DT, Fretier P, Jiang C, Vincent SR. Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons. Synapse 2010; 64: 460-466.
-
(2010)
Synapse
, vol.64
, pp. 460-466
-
-
Lin, D.T.1
Fretier, P.2
Jiang, C.3
Vincent, S.R.4
-
11
-
-
76749172150
-
The d5 dopamine receptor mediates large-conductance, calcium-and voltage-activated potassium channel activation in human coronary artery smooth muscle cells
-
Natarajan A, Han G, Chen SY, Yu P, White R, Jose P. The d5 dopamine receptor mediates large-conductance, calcium-and voltage-activated potassium channel activation in human coronary artery smooth muscle cells. J Pharmacol Exp Ther 2010; 332: 640-649.
-
(2010)
J Pharmacol Exp Ther
, vol.332
, pp. 640-649
-
-
Natarajan, A.1
Han, G.2
Chen, S.Y.3
Yu, P.4
White, R.5
Jose, P.6
-
12
-
-
84903709050
-
Membrane guanylate cyclase, a multimodal transduction machine: History, present, future directions
-
Sharma RK, Duda T. Membrane guanylate cyclase, a multimodal transduction machine: history, present, future directions. Front Mol Neurosci 2014; 7: 56.
-
(2014)
Front Mol Neurosci
, vol.7
, pp. 56
-
-
Sharma, R.K.1
Duda, T.2
-
13
-
-
33748312096
-
NOindependent stimulators and activators of soluble guanylate cyclase: Discovery and therapeutic potential
-
Evgenov OV, Pacher P, Schmidt PM, Haskó G, Schmidt HH, Stasch JP. NOindependent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 2006; 5: 755-768.
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 755-768
-
-
Evgenov, O.V.1
Pacher, P.2
Schmidt, P.M.3
Haskó, G.4
Schmidt, H.H.5
Stasch, J.P.6
-
14
-
-
84897425079
-
Clinical and molecular genetics of the phosphodiesterases (PDEs)
-
Azevedo MF, Faucz FR, Bimpaki E, Horvath A, Levy I, de Alexandre RB et al. Clinical and molecular genetics of the phosphodiesterases (PDEs). Endocr Rev 2014; 35: 195-233.
-
(2014)
Endocr Rev
, vol.35
, pp. 195-233
-
-
Azevedo, M.F.1
Faucz, F.R.2
Bimpaki, E.3
Horvath, A.4
Levy, I.5
De Alexandre, R.B.6
-
15
-
-
33748745120
-
Phosphodiesterase 5 inhibitors-drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles
-
Supuran CT, Mastrolorenzo A, Barbaro G, Scozzafava A. Phosphodiesterase 5 inhibitors-drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles. Curr Pharm Des 2006; 12: 3459-3465.
-
(2006)
Curr Pharm des
, vol.12
, pp. 3459-3465
-
-
Supuran, C.T.1
Mastrolorenzo, A.2
Barbaro, G.3
Scozzafava, A.4
-
16
-
-
33847644982
-
The novel functions of cGMP-specific phosphodiesterase 5 and its inhibitors in carcinoma cells and pulmonary/cardiovascular vessels
-
Zhu B, Strada SJ. The novel functions of cGMP-specific phosphodiesterase 5 and its inhibitors in carcinoma cells and pulmonary/cardiovascular vessels. Curr Top Med Chem 2007; 7: 437-454.
-
(2007)
Curr Top Med Chem
, vol.7
, pp. 437-454
-
-
Zhu, B.1
Strada, S.J.2
-
17
-
-
33750317276
-
Tadalafil, a longacting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke
-
Zhang L, Zhang Z, Zhang RL, Cui Y, LaPointe MC, Silver B et al. Tadalafil, a longacting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke. Brain Res 2006; 1118: 192-198.
-
(2006)
Brain Res
, vol.1118
, pp. 192-198
-
-
Zhang, L.1
Zhang, Z.2
Zhang, R.L.3
Cui, Y.4
LaPointe, M.C.5
Silver, B.6
-
18
-
-
84886640594
-
Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum
-
Flaim KE, Gessner GW, Crooke ST, Sarau HM, Weinstock J. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum. Life Sci 1985; 36: 1427-1436.
-
(1985)
Life Sci
, vol.36
, pp. 1427-1436
-
-
Flaim, K.E.1
Gessner, G.W.2
Crooke, S.T.3
Sarau, H.M.4
Weinstock, J.5
-
19
-
-
0035936042
-
Fenoldopam: A selective peripheral dopamine-receptor agonist for the treatment of severe hypertension
-
Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 2001; 345: 1548-1557.
-
(2001)
N Engl J Med
, vol.345
, pp. 1548-1557
-
-
Murphy, M.B.1
Murray, C.2
Shorten, G.D.3
-
20
-
-
0034051167
-
In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist
-
Ng SS, Pang CC. In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist. Br J Pharmacol 2000; 129: 853-858.
-
(2000)
Br J Pharmacol
, vol.129
, pp. 853-858
-
-
Ng, S.S.1
Pang, C.C.2
-
21
-
-
0023899110
-
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients
-
Weber RR, McCoy CE, Ziemniak JA, Frederickson ED, Goldberg LI, Murphy MB. Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients. Br J Clin Pharmacol 1988; 25: 17-21.
-
(1988)
Br J Clin Pharmacol
, vol.25
, pp. 17-21
-
-
Weber, R.R.1
McCoy, C.E.2
Ziemniak, J.A.3
Frederickson, E.D.4
Goldberg, L.I.5
Murphy, M.B.6
-
22
-
-
60849115247
-
Should we be cautious on the use of commercially available antibodies to dopamine receptors?
-
Bodei S, Arrighi N, Spano P, Sigala S. Should we be cautious on the use of commercially available antibodies to dopamine receptors? Naunyn Schmiedebergs Arch Pharmacol 2009; 379: 413-415.
-
(2009)
Naunyn Schmiedebergs Arch Pharmacol
, vol.379
, pp. 413-415
-
-
Bodei, S.1
Arrighi, N.2
Spano, P.3
Sigala, S.4
-
24
-
-
84926328494
-
Inhibition of iNOS as a novel effective targeted therapy against triple negative breast cancer
-
Granados-Principal S, Liu Y, Guevara ML, Blanco E, Choi DS, Qian W et al. Inhibition of iNOS as a novel effective targeted therapy against triple negative breast cancer. Breast Cancer Res 2015; 17: 527.
-
(2015)
Breast Cancer Res
, vol.17
, pp. 527
-
-
Granados-Principal, S.1
Liu, Y.2
Guevara, M.L.3
Blanco, E.4
Choi, D.S.5
Qian, W.6
-
25
-
-
84861060154
-
Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders
-
Shen LH, Liao MH, Tseng YC. Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders. J Biomed Biotechnol 2012;2012: 259-349.
-
(2012)
J Biomed Biotechnol
, vol.2012
, pp. 259-349
-
-
Shen, L.H.1
Liao, M.H.2
Tseng, Y.C.3
-
26
-
-
64549145847
-
Role of positron-emission tomography scan in the diagnosis and management of breast cancer
-
Almubarak M, Osman S, Marano G, Abraham J. Role of positron-emission tomography scan in the diagnosis and management of breast cancer. Oncology (Williston Park) 2009; 23: 255-261.
-
(2009)
Oncology (Williston Park)
, vol.23
, pp. 255-261
-
-
Almubarak, M.1
Osman, S.2
Marano, G.3
Abraham, J.4
-
27
-
-
84892592536
-
Riociguat: First global approval
-
Conole D, Scott LJ. Riociguat: first global approval. Drugs 2013; 73: 1967-1975.
-
(2013)
Drugs
, vol.73
, pp. 1967-1975
-
-
Conole, D.1
Scott, L.J.2
-
28
-
-
0022980113
-
Steroid, prolactin, dopamine receptors in normal and pathologic breast tissue
-
Carlo RD, Muccioli G, Bellussi G, Portaleoni P, Ghi P, Racca S. Steroid, prolactin, dopamine receptors in normal and pathologic breast tissue. Ann NY Acad Sci 1986; 464: 559-562.
-
(1986)
Ann NY Acad Sci
, vol.464
, pp. 559-562
-
-
Carlo, R.D.1
Muccioli, G.2
Bellussi, G.3
Portaleoni, P.4
Ghi, P.5
Racca, S.6
-
29
-
-
84861995326
-
Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells
-
Sachlos E, Risuenõ RM, Laronde S, Shapovalova Z, Lee JH, Russell J et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell 2012; 149: 1284-1297.
-
(2012)
Cell
, vol.149
, pp. 1284-1297
-
-
Sachlos, E.1
Risuenõ, R.M.2
Laronde, S.3
Shapovalova, Z.4
Lee, J.H.5
Russell, J.6
-
30
-
-
0036897032
-
Dopamine antagonists and the development of breast cancer
-
Wang PS, Walker AM, Tsuang MT, Orav EJ, Glynn RJ, Levin R et al. Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry 2002; 59: 1147-1154.
-
(2002)
Arch Gen Psychiatry
, vol.59
, pp. 1147-1154
-
-
Wang, P.S.1
Walker, A.M.2
Tsuang, M.T.3
Orav, E.J.4
Glynn, R.J.5
Levin, R.6
-
31
-
-
35148895156
-
Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line
-
Zhao DL, Zou LB, Lin S, Shi JG, Zhu HB. Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line. Neuropharmacology 2007; 53: 724-732.
-
(2007)
Neuropharmacology
, vol.53
, pp. 724-732
-
-
Zhao, D.L.1
Zou, L.B.2
Lin, S.3
Shi, J.G.4
Zhu, H.B.5
-
32
-
-
79957926102
-
Dopamine blocks stress-mediated ovarian carcinoma growth
-
Moreno-Smith M, Lu C, Shahzad MM, Pena GN, Allen JK, Stone RL et al. Dopamine blocks stress-mediated ovarian carcinoma growth. Clin Cancer Res 2011; 17: 3649-3659.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 3649-3659
-
-
Moreno-Smith, M.1
Lu, C.2
Shahzad, M.M.3
Pena, G.N.4
Allen, J.K.5
Stone, R.L.6
-
33
-
-
42249112993
-
Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models
-
Sarkar C, Chakroborty D, Chowdhury UR, Dasgupta PS, Basu S. Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models. Clin Cancer Res 2008; 14: 2502-2510.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2502-2510
-
-
Sarkar, C.1
Chakroborty, D.2
Chowdhury, U.R.3
Dasgupta, P.S.4
Basu, S.5
-
34
-
-
0029018929
-
The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells
-
Johnson DE, Ochieng J, Evans SL. The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells. Anticancer Drugs 1995; 6: 471-474.
-
(1995)
Anticancer Drugs
, vol.6
, pp. 471-474
-
-
Johnson, D.E.1
Ochieng, J.2
Evans, S.L.3
-
35
-
-
72649087941
-
Heterodimerization of dopamine receptors: New insights into functional and therapeutic significance
-
Maggio R, Aloisi G, Silvano E, Rossi M, Millan MJ. Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance. Parkinsonism Relat Disord 2009; 15: S2-S7.
-
(2009)
Parkinsonism Relat Disord
, vol.15
, pp. S2-S7
-
-
Maggio, R.1
Aloisi, G.2
Silvano, E.3
Rossi, M.4
Millan, M.J.5
-
36
-
-
0033306462
-
Sources and physiological significance of plasma dopamine sulfate
-
Goldstein DS, Swoboda KJ, Miles JM, Coppack SW, Aneman A, Holmes C et al. Sources and physiological significance of plasma dopamine sulfate. J Clin Endocrinol Metab 1999; 84: 2523-2531.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 2523-2531
-
-
Goldstein, D.S.1
Swoboda, K.J.2
Miles, J.M.3
Coppack, S.W.4
Aneman, A.5
Holmes, C.6
-
38
-
-
34447618279
-
Human sulfatases: A structural perspective to catalysis
-
Ghosh D. Human sulfatases: a structural perspective to catalysis. Cell Mol Life Sci 2007; 64: 2013-2022.
-
(2007)
Cell Mol Life Sci
, vol.64
, pp. 2013-2022
-
-
Ghosh, D.1
-
39
-
-
0033621476
-
X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity
-
Dajani R, Cleasby A, Neu M, Wonacott AJ, Jhoti H, Hood AM et al. X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity. J Biol Chem 1999; 274: 37862-37868.
-
(1999)
J Biol Chem
, vol.274
, pp. 37862-37868
-
-
Dajani, R.1
Cleasby, A.2
Neu, M.3
Wonacott, A.J.4
Jhoti, H.5
Hood, A.M.6
-
40
-
-
34250156365
-
CAMP and cGMP signaling cross-talk: Role of phosphodiesterases and implications for cardiac pathophysiology
-
Zaccolo M, Movsesian MA. cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ Res 2007; 100: 1569-1578.
-
(2007)
Circ Res
, vol.100
, pp. 1569-1578
-
-
Zaccolo, M.1
Movsesian, M.A.2
-
41
-
-
72049113572
-
Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity
-
Hoque KE, Indorkar RP, Sammut S, West AR. Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity. Psychopharmacology (Berl) 2010; 207: 571-581.
-
(2010)
Psychopharmacology (Berl)
, vol.207
, pp. 571-581
-
-
Hoque, K.E.1
Indorkar, R.P.2
Sammut, S.3
West, A.R.4
-
42
-
-
33244477604
-
Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism
-
Sammut S, Dec A, Mitchell D, Linardakis J, Ortiguela M, West AR. Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism. Neuropsychopharmacology 2006; 31: 493-505.
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 493-505
-
-
Sammut, S.1
Dec, A.2
Mitchell, D.3
Linardakis, J.4
Ortiguela, M.5
West, A.R.6
-
43
-
-
0037203543
-
Nitric oxide as a proapoptotic as well as anti-apoptotic modulator
-
Choi BM, Pae HO, Jang SI, Kim YM, Chung HT. Nitric oxide as a proapoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol 2002; 35: 116-126.
-
(2002)
J Biochem Mol Biol
, vol.35
, pp. 116-126
-
-
Choi, B.M.1
Pae, H.O.2
Jang, S.I.3
Kim, Y.M.4
Chung, H.T.5
-
45
-
-
4143067127
-
Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis
-
Basu S, Sarkar C, Chakroborty D, Nagy J, Mitra RB, Dasgupta PS et al. Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis. Cancer Res 2004; 64: 5551-5555.
-
(2004)
Cancer Res
, vol.64
, pp. 5551-5555
-
-
Basu, S.1
Sarkar, C.2
Chakroborty, D.3
Nagy, J.4
Mitra, R.B.5
Dasgupta, P.S.6
-
46
-
-
0035026748
-
The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor
-
Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 2001; 7: 569-574.
-
(2001)
Nat Med
, vol.7
, pp. 569-574
-
-
Basu, S.1
Nagy, J.A.2
Pal, S.3
Vasile, E.4
Eckelhoefer, I.A.5
Bliss, V.S.6
-
47
-
-
65949114869
-
Catecholamines regulate tumor angiogenesis
-
Chakroborty D, Sarkar C, Basu B, Dasgupta PS, Basu S. Catecholamines regulate tumor angiogenesis. Cancer Res 2009; 69: 3727-3730.
-
(2009)
Cancer Res
, vol.69
, pp. 3727-3730
-
-
Chakroborty, D.1
Sarkar, C.2
Basu, B.3
Dasgupta, P.S.4
Basu, S.5
-
48
-
-
4744348385
-
Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, focal adhesion kinase in endothelial cells
-
Sarkar C, Chakroborty D, Mitra RB, Banerjee S, Dasgupta PS, Basu S. Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, focal adhesion kinase in endothelial cells. Am J Physiol Heart Circ Physiol 2004; 287: H1554-H1560.
-
(2004)
Am J Physiol Heart Circ Physiol
, vol.287
, pp. H1554-H1560
-
-
Sarkar, C.1
Chakroborty, D.2
Mitra, R.B.3
Banerjee, S.4
Dasgupta, P.S.5
Basu, S.6
|